AKBA
Akebia Therapeutics Inc.
$2.79
+$0.01(+0.36%)
27
Overall
20
Value
20
Tech
42
Quality
Market Cap
$782.18M
Volume
1.65M
52W Range
$1.30 - $4.08
Target Price
$7.40
Key Metrics Overview
| Market Cap | $782.18M | P/E Ratio | 93.00 |
| 52W High | $4.08 | 52W Low | $1.30 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 42.1% | 52W Position | 53.6% |
| Overall Score | 27 | Value Score | 20 |
| Quality Score | 42 | Technical Score | 20 |
Growth Analysis
| EPS Current Est | $0.03 | EPS Next Est | $0.23 |
| EPS Growth Est | +666.7% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AKBA | $2.79 | +0.4% | 1.65M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Akebia Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW